Medicines

Medicines help to prevent, treat or cure disease. Some are available over the counter, others need a prescription from a health practitioner. Find out what we’re doing to help make sure medicines in Australia are safe, good quality and accessible, and do what they say they will do.

About medicines

The different types of medicines and how they are classified.

What we do

How we make sure medicines are as safe and effective as possible.

Access to medicines

How you can access medicines and how we manage shortages.

Cost of medicines

How we keep medicines affordable for Australians.

Pharmaceutical Benefits Scheme

The Pharmaceutical Benefits Scheme (PBS) subsidises a large number of medicines to keep their cost down for Australians.

Read about the PBS

Biosimilar medicines

Some pharmaceutical companies make medicines that are very similar to existing biological medicines. These are known as biosimilar medicines. We have resources available to help you understand and have confidence in biosimilar medicines.

Biosimilar medicines resource collection

Latest news

Latest news

Medical receptionist sentenced to jail for more than $253k of Medicare fraud

A medical receptionist from south-eastern Queensland has been convicted after fraudulently claiming more than $253,000 in Medicare payments.

Protecting Older Australians – COVID-19 newsletter – 20 January 2023

In this issue: Learn about COVID-19 safe behaviours, reducing risk to staff and visitors, using PPE and accessing oral antiviral treatments.

Medicines Line

1300 633 424

Contact Medicines Line on 1300 MEDICINE for information on prescription, over-the-counter and other medicines (such as complementary medicines). The service is available Monday to Friday, 9 am to 5 pm AEST (excluding Victorian public holidays).

Latest resources

Latest resources

Life Saving Drugs Program – MPS II – Review summary and expert panel recommendations for consumers

This MPS II review considered idursulfase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.

Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations for consumers

This Gaucher disease review considered 3 enzyme replacement therapies (ERTs), imiglucerase, velaglucerase and taliglucerase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health.

Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations

This Gaucher disease review considered three enzyme replacement therapies (ERTs), imiglucerase, velaglucerase and taliglucerase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.

Life Saving Drugs Program – Pompe disease – Review summary and expert panel recommendations

This Pompe disease review considered alglucosidase alfa. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.